1	Scientists	scientist	NNS	_	3	nsubj	3:A0=PAG
2	have	have	VBP	_	3	aux	_
3	used	use	VBN	pb=use.01	0	root	_
4	small	small	JJ	_	6	hmod	_
5	-	-	HYPH	_	6	hyph	_
6	angle	angle	NN	_	7	nn	_
7	neutron	neutron	NN	_	18	nn	_
8	scattering	scatter	VBG	p2=NN|pb=scatter.01	7	partmod	_
9	(	(	-LRB-	_	10	punct	_
10	SANS	sans	NNP	p2=NNPS	8	dobj	8:A1=PPT
11	)	)	-RRB-	_	10	punct	_
12	and	and	CC	_	7	cc	_
13	neutron	neutron	NN	_	7	conj	_
14	spin-echo	spin-echo	NNP	p2=NN	18	nn	_
15	(	(	-LRB-	_	16	punct	_
16	NSE	nse	NNP	_	14	appos	_
17	)	)	-RRB-	_	16	punct	_
18	techniques	technique	NNS	p2=VBZ	3	dobj	3:A1=PPT
19	for	for	IN	_	3	prep	3:R-AM-TMP
20	the	the	DT	_	22	det	_
21	first	#ord#	JJ	_	22	amod	_
22	time	time	NN	_	19	pobj	_
23	to	to	TO	_	24	aux	_
24	understand	understand	VB	pb=understand.01	22	infmod	_
25	how	how	WRB	_	26	advmod	_
26	monoclonal	monoclonal	JJ	p2=FW	27	amod	_
27	antibodies	antibody	NNS	_	24	dobj	24:A1=PPT
28	(	(	-LRB-	_	27	punct	_
29	mAbs	mabs	NNP	p2=NNS	27	appos	_
30	)	)	-RRB-	_	27	punct	_
31	,	,	,	_	27	punct	_
32	a	a	DT	_	33	det	_
33	class	class	NN	_	27	appos	_
34	of	of	IN	_	33	prep	_
35	targeted	target	VBN	p2=JJ|pb=target.01	36	amod	_
36	biopharmaceuticals	biopharmaceuticals	NNS	_	34	pobj	35:A1=PPT;37:A1=PPT
37	used	use	VBN	p2=VBD|pb=use.01	36	partmod	_
38	to	to	TO	_	39	aux	_
39	treat	treat	VB	pb=treat.03	37	xcomp	37:A2=PRP
40	autoimmune	autoimmune	NN	p2=JJ	41	nn	_
41	disorders	disorder	NNS	_	39	dobj	39:A1=PPT
42	and	and	CC	_	41	cc	_
43	cancer	cancer	NN	_	41	conj	_
44	,	,	,	_	39	punct	_
45	dynamically	dynamically	RB	p2=NN	39	advmod	_
46	cluster	cluster	NN	_	39	dobj	39:A2=PPT
47	and	and	CC	_	39	cc	_
48	move	move	VB	p2=NN|pb=move.01	39	conj	_
49	in	in	IN	p2=RB	48	prep	48:AM-DIR
50	high	high	JJ	_	51	amod	_
51	concentration	concentration	NN	_	52	nn	_
52	solutions	solution	NNS	_	49	pobj	_
53	.	.	.	_	3	punct	_

1	Certain	certain	JJ	_	4	amod	_
2	mAb	mab	JJ	p2=NNP	4	amod	_
3	cluster	cluster	NN	_	4	nn	_
4	arrangements	arrangement	NNS	_	6	nsubj	6:A0=PAG
5	can	can	MD	_	6	aux	6:AM-MOD
6	thicken	thicken	VB	p2=DT|pb=thicken.01	13	ccomp	_
7	pharmaceutical	pharmaceutical	JJ	p2=NN	8	amod	_
8	solutions	solution	NNS	_	6	dobj	6:A1=PPT
9	;	;	:	p2=,	13	punct	_
10	they	they	PRP	_	13	nsubj	13:A0=CAU
11	could	could	MD	_	13	aux	13:AM-MOD
12	thus	thus	RB	_	13	advmod	13:AM-ADV
13	limit	limit	VB	pb=limit.01	0	root	_
14	the	the	DT	_	16	det	_
15	feasible	feasible	JJ	_	16	amod	_
16	concentration	concentration	NN	_	13	dobj	13:A1=PPT
17	of	of	IN	_	16	prep	_
18	injectables	injectables	NNS	p2=FW	17	pobj	19:A1=PPT
19	administered	administer	VBN	pb=administer.01	18	partmod	_
20	to	to	IN	_	19	prep	19:A2=GOL
21	patients	patient	NNS	_	20	pobj	_
22	around	around	IN	_	21	prep	_
23	the	the	DT	_	24	det	_
24	world	world	NN	_	22	pobj	_
25	.	.	.	_	13	punct	_

1	The	the	DT	_	2	det	_
2	insights	insight	NNS	_	55	nsubj	3:A1;55:A1=PPT
3	provided	provided	VBN	pb=provide.01	2	partmod	_
4	by	by	IN	_	3	agent	3:A0
5	a	a	DT	_	6	det	_
6	team	team	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	neutron	neutron	NN	_	9	nn	_
9	scientists	scientist	NNS	_	7	pobj	_
10	from	from	IN	_	9	prep	_
11	the	the	DT	_	13	det	_
12	National	national	NNP	_	13	nn	_
13	Center	center	NNP	_	10	pobj	_
14	of	of	IN	_	13	prep	_
15	Neutron	neutron	NNP	_	16	nn	_
16	Research	research	NNP	_	14	pobj	_
17	(	(	-LRB-	_	13	punct	_
18	NCNR	ncnr	NNP	_	13	appos	_
19	)	)	-RRB-	_	13	punct	_
20	and	and	CC	_	9	cc	_
21	the	the	DT	_	25	det	_
22	Institut	institut	NNP	p2=JJ	25	nn	_
23	Laue	laue	NNP	_	25	hmod	_
24	-	-	HYPH	p2=,	25	hyph	_
25	Langevin	langevin	NNP	_	55	nsubj	_
26	(	(	-LRB-	_	27	punct	_
27	ILL	ill	NNP	_	25	appos	_
28	)	)	-RRB-	_	27	punct	_
29	,	,	,	_	55	punct	_
30	in	in	IN	_	55	prep	_
31	collaboration	collaboration	NN	_	30	pobj	_
32	with	with	IN	_	31	prep	_
33	colloid	colloid	NN	p2=JJ	36	nn	_
34	and	and	CC	_	33	cc	_
35	proteins	protein	NNS	p2=VBZ	33	conj	_
36	scientists	scientist	NNS	_	32	pobj	_
37	at	at	IN	_	36	prep	_
38	the	the	DT	_	39	det	_
39	University	university	NNP	_	37	pobj	_
40	of	of	IN	_	39	prep	_
41	Delaware	delaware	NNP	_	40	pobj	_
42	and	and	CC	_	36	cc	_
43	biopharmaceutical	biopharmaceutical	JJ	p2=NN	44	amod	_
44	company	company	NN	_	45	nn	_
45	Genentech	genentech	NNP	_	36	conj	_
46	(	(	-LRB-	_	45	punct	_
47	a	a	DT	_	48	det	_
48	member	member	NN	_	45	appos	_
49	of	of	IN	_	48	prep	_
50	the	the	DT	_	52	det	_
51	Roche	roche	NNP	_	52	nn	_
52	group	group	NN	p2=NNP	49	pobj	_
53	)	)	-RRB-	_	45	punct	_
54	,	,	,	_	55	punct	_
55	are	be	VBP	pb=be.01	0	root	_
56	an	an	DT	_	58	det	_
57	important	important	JJ	_	58	amod	_
58	step	step	NN	_	55	attr	55:A2=PRD
59	towards	towards	IN	_	58	prep	_
60	the	the	DT	_	61	det	_
61	development	development	NN	_	59	pobj	_
62	and	and	CC	_	61	cc	_
63	manufacture	manufacture	NN	p2=VB	61	conj	_
64	of	of	IN	_	61	prep	_
65	high	high	JJ	_	67	hmod	_
66	-	-	HYPH	_	67	hyph	_
67	concentration	concentration	NN	_	68	nn	_
68	biopharmaceuticals	biopharmaceuticals	NNS	_	64	pobj	69:A1=PPT
69	needed	need	VBN	pb=need.01	68	partmod	_
70	for	for	IN	_	69	prep	69:AM-PRP
71	high	high	JJ	_	73	hmod	_
72	-	-	HYPH	_	73	hyph	_
73	dose	dose	NN	_	74	nn	_
74	indications	indication	NNS	_	70	pobj	_
75	and	and	CC	_	74	cc	_
76	potential	potential	JJ	p2=NN	79	amod	_
77	self	self	NN	_	79	hmod	_
78	-	-	HYPH	_	79	hyph	_
79	administration	administration	NN	_	74	conj	_
80	at	at	IN	_	79	prep	_
81	home	home	NN	_	80	pobj	_
82	.	.	.	_	55	punct	_

1	Monoclonal	monoclonal	JJ	p2=NNP	2	amod	_
2	antibodies	antibody	NNS	_	7	nsubj	17:A0=PAG;9:A1=PPT
3	(	(	-LRB-	_	2	punct	_
4	mAbs	mabs	NNS	p2=NNPS	2	appos	_
5	)	)	-RRB-	_	2	punct	_
6	are	be	VBP	_	7	aux	_
7	proving	prove	VBG	pb=prove.01	0	root	_
8	to	to	TO	_	9	aux	_
9	be	be	VB	pb=be.01	7	xcomp	7:C-A1
10	a	a	DT	_	12	det	_
11	vital	vital	JJ	_	12	amod	_
12	tool	tool	NN	_	9	attr	9:A2=PRD
13	in	in	IN	_	12	prep	_
14	modern	modern	JJ	_	15	amod	_
15	pharmacology	pharmacology	NN	_	13	pobj	_
16	,	,	,	_	7	punct	_
17	providing	provide	VBG	pb=provide.01	7	advcl	_
18	the	the	DT	_	19	det	_
19	basis	basis	NN	_	17	dobj	17:A1=PPT
20	for	for	IN	_	19	prep	_
21	a	a	DT	_	23	det	_
22	growing	grow	VBG	pb=grow.01	23	amod	_
23	number	number	NN	_	20	pobj	22:A1=PPT
24	of	of	IN	_	23	prep	_
25	successful	successful	JJ	_	26	amod	_
26	drugs	drug	NNS	_	24	pobj	_
27	for	for	IN	_	23	prep	_
28	cancer	cancer	NN	_	31	nn	_
29	and	and	CC	_	28	cc	_
30	autoimmune	autoimmune	NN	p2=JJ	28	conj	_
31	disorders	disorder	NNS	_	27	pobj	_
32	such	such	JJ	_	33	amod	_
33	as	as	IN	_	31	prep	_
34	arthritis	arthritis	NN	_	33	pobj	_
35	and	and	CC	_	34	cc	_
36	multiple	multiple	JJ	_	37	amod	_
37	sclerosis	sclerosis	NN	_	34	conj	_
38	.	.	.	_	7	punct	_

1	As	as	IN	_	13	prep	13:AM-ADV
2	agents	agent	NNS	_	1	pobj	_
3	for	for	IN	_	2	prep	_
4	targeted	target	VBN	p2=JJ|pb=target.01	5	amod	_
5	therapy	therapy	NN	_	3	pobj	4:A1=PPT
6	with	with	IN	_	5	prep	_
7	a	a	DT	_	10	det	_
8	good	good	JJ	_	10	amod	_
9	safety	safety	NN	_	10	nn	_
10	profile	profile	NN	_	6	pobj	_
11	,	,	,	_	13	punct	_
12	they	they	PRP	_	13	nsubj	13:A1=PPT
13	are	be	VBP	pb=be.01	0	root	_
14	an	an	DT	_	15	det	_
15	alternative	alternative	NN	p2=JJ	13	attr	13:A2=PRD
16	to	to	IN	_	15	prep	_
17	harsher	harsh	JJR	_	19	amod	_
18	chemotherapy	chemotherapy	NN	_	19	nn	_
19	treatment	treatment	NN	_	16	pobj	_
20	.	.	.	_	13	punct	_

1	The	the	DT	_	2	det	_
2	mAbs	mabs	NNS	p2=NNP	3	nsubj	3:A0=PAG;5:A0=PAG
3	work	work	VBP	p2=NN|pb=work.01	0	root	_
4	by	by	IN	_	3	prep	3:AM-MNR
5	attaching	attach	VBG	pb=attach.01	4	pcomp	_
6	themselves	themselves	PRP	_	5	dobj	5:A1=PPT
7	to	to	IN	_	5	prep	5:C-A1
8	specific	specific	JJ	_	10	amod	_
9	protein	protein	NN	_	10	nn	_
10	targets	target	NNS	_	7	pobj	_
11	on	on	IN	_	10	prep	_
12	cancerous	cancerous	JJ	_	13	amod	_
13	cells	cell	NNS	_	11	pobj	_
14	,	,	,	_	5	punct	_
15	or	or	CC	_	5	cc	_
16	blocking	block	VBG	pb=block.01	5	conj	_
17	target	target	NN	_	18	nn	_
18	proteins	protein	NNS	_	16	dobj	16:A1
19	in	in	IN	_	16	prep	16:AM-TMP
20	a	a	DT	_	23	det	_
21	known	know	VBN	p2=JJ|pb=know.01	23	amod	_
22	biochemical	biochemical	JJ	p2=NN	23	amod	_
23	pathway	pathway	NN	_	19	pobj	21:A1=PPT
24	responsible	responsible	JJ	_	23	amod	_
25	for	for	IN	_	24	prep	_
26	a	a	DT	_	27	det	_
27	disease	disease	NN	_	25	pobj	_
28	.	.	.	_	3	punct	_

1	These	these	DT	_	2	det	_
2	treatments	treatment	NNS	_	4	nsubj	4:A0=PAG
3	usually	usually	RB	_	4	advmod	4:AM-TMP
4	require	require	VBP	pb=require.01	0	root	_
5	high	high	JJ	_	6	amod	_
6	doses	dose	NNS	_	4	dobj	4:A1=PPT
7	,	,	,	_	4	punct	_
8	and	and	CC	_	4	cc	_
9	lately	lately	RB	_	10	advmod	_
10	in	in	IN	_	15	prep	15:AM-LOC
11	some	some	DT	_	12	det	_
12	indications	indication	NNS	_	10	pobj	_
13	there	there	EX	p2=RB	15	expl	_
14	has	have	VBZ	p2=VBP	15	aux	_
15	been	be	VBN	pb=be.02	4	conj	_
16	considerable	considerable	JJ	_	17	amod	_
17	interest	interest	NN	_	15	attr	15:A1=PPT
18	in	in	IN	_	17	prep	_
19	moving	move	VBG	pb=move.01	18	pcomp	_
20	from	from	IN	_	19	prep	19:AM-DIR
21	intravenous	intravenous	JJ	p2=NNP	25	amod	_
22	(	(	-LRB-	_	25	punct	_
23	IV	iv	NNP	p2=NN	25	nn	_
24	)	)	-RRB-	_	25	punct	_
25	delivery	delivery	NN	_	20	pobj	_
26	to	to	IN	_	25	prep	_
27	a	a	DT	_	34	det	_
28	more	more	RBR	_	29	advmod	_
29	convenient	convenient	JJ	_	34	amod	_
30	subcutaneous	subcutaneous	JJ	p2=NNS	34	amod	_
31	(	(	-LRB-	_	34	punct	_
32	SC	sc	NNP	p2=JJ	34	nn	_
33	)	)	-RRB-	_	34	punct	_
34	delivery	delivery	NN	_	26	pobj	_
35	-	-	:	p2=,	34	punct	_
36	a	a	DT	_	38	det	_
37	shallow	shallow	JJ	_	38	amod	_
38	injection	injection	NN	_	34	appos	_
39	into	into	IN	_	38	prep	_
40	the	the	DT	_	41	det	_
41	cutis	cutis	NN	p2=NNS	39	pobj	_
42	just	just	RB	_	43	advmod	_
43	below	below	IN	_	41	prep	_
44	the	the	DT	_	45	det	_
45	skin	skin	NN	_	43	pobj	_
46	(	(	-LRB-	_	48	punct	_
47	such	such	JJ	_	48	amod	_
48	as	as	IN	_	45	prep	_
49	the	the	DT	_	51	det	_
50	home	home	NN	_	51	nn	_
51	treatments	treatment	NNS	_	48	pobj	52:A1=PPT
52	offered	offer	VBN	p2=VBD|pb=offer.01	51	partmod	_
53	to	to	IN	_	52	prep	52:A3=GOL
54	sufferers	sufferer	NNS	_	53	pobj	_
55	of	of	IN	_	54	prep	_
56	type	type	NN	_	58	nn	_
57	1	0	CD	_	58	num	_
58	diabetes	diabetes	NN	_	55	pobj	_
59	)	)	-RRB-	_	48	punct	_
60	.	.	.	_	15	punct	_

1	However	however	RB	_	6	advmod	6:AM-DIS
2	,	,	,	_	6	punct	_
3	progress	progress	NN	_	6	nsubjpass	6:A1=PPT
4	has	have	VBZ	_	6	aux	_
5	been	be	VBN	_	6	auxpass	_
6	hampered	hamper	VBN	pb=hamper.01	0	root	_
7	by	by	IN	_	6	agent	6:A0=PAG
8	the	the	DT	_	10	det	_
9	high	high	JJ	_	10	amod	_
10	viscosity	viscosity	NN	_	7	pobj	_
11	of	of	IN	_	10	prep	_
12	solutions	solution	NNS	_	11	pobj	13:A0
13	containing	contain	VBG	pb=contain.01	12	partmod	_
14	high	high	JJ	_	15	amod	_
15	amounts	amount	NNS	_	13	dobj	13:A1
16	of	of	IN	_	15	prep	_
17	mAbs	mabs	NNS	p2=NNP	16	pobj	_
18	,	,	,	_	6	punct	_
19	and	and	CC	_	6	cc	_
20	this	this	DT	_	21	nsubj	21:A0=PAG
21	provides	provide	VBZ	pb=provide.01	6	conj	_
22	challenges	challenge	NNS	_	21	dobj	21:A1=PPT
23	to	to	IN	p2=TO	21	prep	21:A2=GOL
24	efficient	efficient	JJ	_	30	amod	_
25	and	and	CC	_	24	cc	_
26	economical	economical	JJ	_	24	conj	_
27	large	large	JJ	_	29	hmod	_
28	-	-	HYPH	_	29	hyph	_
29	scale	scale	NN	_	30	nn	_
30	production	production	NN	_	23	pobj	_
31	,	,	,	_	30	punct	_
32	purification	purification	NN	_	30	conj	_
33	,	,	,	_	32	punct	_
34	and	and	CC	_	32	cc	_
35	delivery	delivery	NN	_	32	conj	_
36	of	of	IN	_	35	prep	_
37	these	these	DT	_	38	det	_
38	drugs	drug	NNS	_	36	pobj	_
39	.	.	.	_	21	punct	_

1	"	"	``	p2=''	17	punct	_
2	For	for	IN	_	17	prep	17:AM-ADV
3	some	some	DT	_	4	det	_
4	proteins	protein	NNS	_	2	pobj	_
5	at	at	IN	_	4	prep	_
6	concentrations	concentration	NNS	_	5	pobj	_
7	higher	high	JJR	_	6	amod	_
8	than	than	IN	_	7	prep	_
9	100	0	CD	_	10	num	_
10	mg	mg	NNS	p2=NN	8	pobj	_
11	/	/	SYM	p2=,	12	punct	_
12	ml	ml	NN	p2=RB	10	appos	_
13	,	,	,	_	17	punct	_
14	you	you	PRP	_	17	nsubj	17:A0=PAG
15	ca	can	MD	_	17	aux	17:AM-MOD
16	n't	not	RB	_	17	neg	17:AM-NEG
17	deliver	deliver	VB	pb=deliver.01	29	ccomp	_
18	them	them	PRP	_	17	dobj	17:A1=PPT
19	fast	fast	RB	p2=VB	20	advmod	_
20	enough	enough	RB	p2=JJ	17	advmod	17:AM-TMP
21	through	through	IN	p2=RB	17	prep	17:AM-MNR
22	thin	thin	JJ	_	21	pobj	_
23	,	,	,	_	29	punct	_
24	SC	sc	NNP	p2=JJ	26	nn	_
25	injection	injection	NN	_	26	nn	_
26	needles	needle	NNS	_	29	nsubj	_
27	,	,	,	_	29	punct	_
28	so	so	RB	p2=CC	29	advmod	_
29	repeat	repeat	VB	p2=VBP	30	nn	_
30	visits	visit	NNS	_	38	nsubjpass	38:A1=PPT
31	to	to	IN	_	30	prep	_
32	the	the	DT	_	33	det	_
33	hospital	hospital	NN	_	31	pobj	_
34	with	with	IN	_	30	prep	_
35	intravenous	intravenous	JJ	_	36	amod	_
36	drips	drip	NNS	_	34	pobj	_
37	are	be	VBP	_	38	auxpass	_
38	needed	need	VBN	pb=need.01	41	ccomp	41:A1=PPT
39	,	,	,	_	41	punct	_
40	"	"	''	_	41	punct	_
41	explains	explain	VBZ	pb=explain.01	0	root	_
42	Prof.	prof.	NNP	_	44	nn	_
43	Yun	yun	NNP	_	44	nn	_
44	Liu	liu	NNP	_	41	nsubj	41:A0
45	from	from	IN	_	44	prep	_
46	the	the	DT	_	48	det	_
47	National	national	NNP	_	48	nn	_
48	Center	center	NNP	_	45	pobj	_
49	of	of	IN	_	48	prep	_
50	Neutron	neutron	NNP	_	51	nn	_
51	Research	research	NNP	_	49	pobj	_
52	(	(	-LRB-	_	48	punct	_
53	NCNR	ncnr	NNP	_	48	appos	_
54	)	)	-RRB-	_	48	punct	_
55	in	in	IN	_	44	prep	_
56	the	the	DT	_	57	det	_
57	US	us	NNP	_	55	pobj	_
58	,	,	,	_	44	punct	_
59	who	who	WP	_	62	nsubjpass	62:R-A1
60	is	be	VBZ	_	62	auxpass	_
61	also	also	RB	_	62	advmod	62:AM-ADV
62	affiliated	affiliate	VBN	p2=JJ|pb=affiliate.01	44	rcmod	_
63	with	with	IN	_	62	prep	62:A2=PPT
64	the	the	DT	_	65	det	_
65	University	university	NNP	_	63	pobj	_
66	of	of	IN	_	65	prep	_
67	Delaware	delaware	NNP	_	66	pobj	_
68	.	.	.	_	41	punct	_

1	"	"	``	_	6	punct	_
2	The	the	DT	_	3	det	_
3	thickening	thickening	NN	_	6	nsubj	6:A0=CAU
4	may	may	MD	_	6	aux	6:AM-MOD
5	also	also	RB	_	6	advmod	6:AM-DIS
6	cause	cause	VB	pb=cause.01	0	root	_
7	problems	problem	NNS	_	6	dobj	6:A1=PPT
8	in	in	IN	_	7	prep	_
9	processing	processing	NN	_	8	pobj	_
10	,	,	,	_	9	punct	_
11	when	when	WRB	_	14	advmod	14:R-AM-TMP
12	filtration	filtration	NN	_	13	nn	_
13	pressures	pressure	NNS	_	14	nsubj	14:A1=PPT
14	are	be	VBP	pb=be.01	6	advcl	6:AM-TMP
15	too	too	RB	_	16	advmod	_
16	high	high	JJ	_	14	acomp	14:A2=PRD
17	,	,	,	_	6	punct	_
18	for	for	IN	_	3	prep	_
19	example	example	NN	_	18	pobj	_
20	,	,	,	_	18	punct	_
21	or	or	CC	_	18	cc	_
22	during	during	IN	p2=VBG	18	conj	_
23	freeze	freeze	NN	p2=VB	22	pobj	_
24	and	and	CC	_	23	cc	_
25	thaw	thaw	NN	p2=NNS	23	conj	_
26	in	in	IN	_	23	prep	_
27	large	large	JJ	_	28	amod	_
28	tanks	tank	NNS	_	26	pobj	40:AM-LOC
29	where	where	WRB	_	40	advmod	40:R-AM-LOC
30	potential	potential	JJ	p2=NN	31	amod	_
31	gelation	gelation	NN	_	40	nsubj	40:A1=PPT
32	or	or	CC	_	31	cc	_
33	phase	phase	NN	_	34	nn	_
34	separation	separation	NN	_	31	conj	_
35	of	of	IN	_	34	prep	_
36	the	the	DT	_	38	det	_
37	freeze	freeze	NN	p2=JJ	38	nn	_
38	concentrate	concentrate	NN	p2=VBP	35	pobj	_
39	can	can	MD	_	40	aux	40:AM-MOD
40	occur	occur	VB	pb=occur.01	28	rcmod	_
41	.	.	.	_	6	punct	_
42	"	"	''	_	6	punct	_

1	As	as	IN	_	18	prep	18:AM-DIS
2	a	a	DT	_	3	det	_
3	result	result	NN	_	1	pobj	_
4	,	,	,	_	18	punct	_
5	efforts	effort	NNS	_	18	nsubjpass	18:A1=PPT
6	to	to	TO	_	7	aux	_
7	find	find	VB	pb=find.01	5	infmod	_
8	ways	way	NNS	_	7	dobj	7:A1=PPT;10:AM-MNR
9	to	to	TO	_	10	aux	_
10	raise	raise	VB	pb=raise.01	8	infmod	_
11	the	the	DT	_	12	det	_
12	concentration	concentration	NN	_	10	dobj	10:A1=PPT
13	of	of	IN	_	12	prep	_
14	monoclonal	monoclonal	JJ	_	16	amod	_
15	antibody	antibody	NN	_	16	nn	_
16	pharmaceuticals	pharmaceutical	NNS	_	13	pobj	_
17	are	be	VBP	_	18	auxpass	_
18	focused	focus	VBN	p2=JJ|pb=focus.01	0	root	_
19	on	on	IN	_	18	prep	18:A2=PPT
20	understanding	understand	VBG	pb=understand.01	19	pcomp	_
21	the	the	DT	_	23	det	_
22	root	root	NN	_	23	nn	_
23	cause	cause	NN	_	20	dobj	20:A1=PPT
24	of	of	IN	_	23	prep	_
25	this	this	DT	_	26	det	_
26	thickening	thickening	NN	_	24	pobj	_
27	.	.	.	_	18	punct	_

1	Previous	previous	JJ	_	2	amod	_
2	studies	study	NNS	_	0	root	3:A0=PAG
3	using	use	VBG	pb=use.01	2	partmod	_
4	static	static	JJ	_	5	amod	_
5	light	light	NN	p2=JJ	19	nsubj	6:A0=PAG;19:A0=PAG
6	scattering	scatter	VBG	pb=scatter.01	5	partmod	_
7	(	(	-LRB-	_	10	punct	_
8	Lilyestrom	lilyestrom	NNP	p2=IN	10	nn	_
9	et	et	NN	p2=NNP	10	nn	_
10	al	al	NNP	p2=NN	6	dobj	6:A1=PPT
11	,	,	,	_	10	punct	_
12	2013	0	CD	p2=LS	10	npadvmod	_
13	)	)	-RRB-	_	10	punct	_
14	on	on	IN	_	6	prep	6:A2=GOL
15	concentrated	concentrated	JJ	p2=VBN	17	amod	_
16	mAb	mab	NNP	p2=JJ	17	nn	_
17	solutions	solution	NNS	_	14	pobj	_
18	had	have	VBD	_	19	aux	_
19	suggested	suggest	VBN	pb=suggest.01	2	rcmod	_
20	a	a	DT	_	22	det	_
21	strong	strong	JJ	_	22	amod	_
22	link	link	NN	_	19	dobj	19:A1=PPT
23	between	between	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	development	development	NN	_	29	nn	_
26	of	of	IN	_	25	prep	_
27	protein	protein	NN	_	26	pobj	_
28	clustering	cluster	VBG	p2=NN	29	nn	_
29	formations	formation	NNS	_	23	pobj	_
30	and	and	CC	_	29	cc	_
31	increases	increase	NNS	_	29	conj	_
32	in	in	IN	_	29	prep	_
33	viscosity	viscosity	NN	_	32	pobj	_
34	.	.	.	_	2	punct	_

1	In	in	IN	_	8	prep	_
2	this	this	DT	_	4	det	_
3	latest	late	JJS	_	4	amod	_
4	study	study	NN	_	1	pobj	_
5	(	(	-LRB-	_	4	punct	_
6	Yearley	yearley	NNP	p2=NN	8	nn	_
7	et	et	NN	p2=NNP	8	nn	_
8	al	al	NN	p2=NNP	0	root	_
9	.	.	.	_	1	punct	_

1	2014	0	CD	p2=LS	3	meta	_
2	)	)	-RRB-	_	3	punct	_
3	led	lead	VBN	pb=lead.02	0	root	_
4	by	by	IN	_	3	agent	3:A0=PAG
5	Prof.	prof.	NNP	_	7	nn	_
6	Yun	yun	NNP	_	7	nn	_
7	Liu	liu	NNP	_	4	pobj	_
8	(	(	-LRB-	_	9	punct	_
9	NCNR	ncnr	NNP	_	7	appos	_
10	)	)	-RRB-	_	9	punct	_
11	and	and	CC	_	7	cc	_
12	Dr.	dr.	NNP	_	14	nn	_
13	Dan	dan	NNP	_	14	nn	_
14	Zarraga	zarraga	NNP	_	7	conj	_
15	from	from	IN	_	14	prep	_
16	Genentech	genentech	NNP	_	15	pobj	_
17	,	,	,	_	48	punct	_
18	in	in	IN	_	48	prep	_
19	collaboration	collaboration	NN	_	18	pobj	_
20	with	with	IN	_	19	prep	_
21	the	the	DT	_	25	det	_
22	Institut	institut	NNP	p2=NNPS	25	nn	_
23	Laue	laue	NNP	_	25	hmod	_
24	-	-	HYPH	p2=,	25	hyph	_
25	Langevin	langevin	NNP	_	36	nn	_
26	(	(	-LRB-	_	27	punct	_
27	ILL	ill	NNP	_	25	appos	_
28	)	)	-RRB-	_	27	punct	_
29	in	in	IN	_	25	prep	_
30	Grenoble	grenoble	NNP	p2=JJ	29	pobj	_
31	,	,	,	_	48	punct	_
32	small	small	JJ	_	34	hmod	_
33	-	-	HYPH	_	34	hyph	_
34	angle	angle	NN	_	35	nn	_
35	neutron	neutron	NN	_	42	nn	_
36	scattering	scatter	VBG	p2=NN|pb=scatter.01	35	partmod	_
37	(	(	-LRB-	_	38	punct	_
38	SANS	sans	NNP	p2=NNPS	36	dobj	36:A1=PPT
39	)	)	-RRB-	_	38	punct	_
40	and	and	CC	_	35	cc	_
41	neutron	neutron	NN	_	35	conj	_
42	spin-echo	spin-echo	NNP	p2=NN	46	nn	_
43	(	(	-LRB-	_	44	punct	_
44	NSE	nse	NNP	_	42	appos	_
45	)	)	-RRB-	_	44	punct	_
46	techniques	technique	NNS	_	48	nsubjpass	50:A0=PAG;48:A1=PPT
47	were	be	VBD	_	48	auxpass	_
48	used	use	VBN	p2=JJ|pb=use.01	3	conj	_
49	to	to	TO	_	50	aux	_
50	study	study	VB	pb=study.01	48	xcomp	48:A2=PRP
51	the	the	DT	_	52	det	_
52	structure	structure	NN	_	50	dobj	50:A1=PPT
53	and	and	CC	_	52	cc	_
54	dynamics	dynamic	NNS	_	52	conj	_
55	of	of	IN	_	52	prep	_
56	mAb	mab	NNP	p2=JJ	55	pobj	_
57	clustering	cluster	VBG	p2=NN|pb=cluster.01	50	advcl	_
58	responsible	responsible	JJ	_	57	acomp	57:A1=PPT
59	for	for	IN	_	58	prep	_
60	the	the	DT	_	63	det	_
61	bulk	bulk	NN	p2=JJ	62	amod	_
62	solution	solution	NN	_	63	nn	_
63	properties	property	NNS	_	59	pobj	_
64	.	.	.	_	48	punct	_

1	Two	#crd#	CD	_	2	num	_
2	types	type	NNS	_	6	nsubjpass	6:A1=PPT
3	of	of	IN	_	2	prep	_
4	antibody	antibody	NN	_	3	pobj	_
5	were	be	VBD	_	6	auxpass	_
6	placed	place	VBN	pb=place.01	0	root	_
7	in	in	IN	_	6	prep	6:A2=GOL
8	solution	solution	NN	_	10	hmod	_
9	-	-	HYPH	p2=:	10	hyph	_
10	one	#crd#	CD	p2=NN	7	pobj	11:A1=PPT
11	known	know	VBN	p2=NN|pb=know.01	10	partmod	_
12	to	to	TO	_	13	aux	_
13	increase	increase	VB	pb=increase.01	11	xcomp	11:A2=PRD
14	solution	solution	NN	_	15	nn	_
15	viscosity	viscosity	NN	_	13	dobj	13:A1=PPT
16	and	and	CC	_	13	cc	_
17	one	#crd#	CD	p2=NN	13	conj	29:A1
18	which	which	WDT	_	29	dobj	29:R-A1
19	did	do	VBD	_	22	aux	_
20	not	not	RB	_	22	hmod	_
21	-	-	HYPH	p2=VB	22	hyph	_
22	so	so	RB	p2=VB	29	advmod	29:AM-DIS
23	any	any	DT	p2=JJ	24	det	_
24	differences	difference	NNS	_	29	nsubjpass	29:A1=PAG
25	in	in	IN	_	24	prep	_
26	behaviour	behaviour	NN	_	25	pobj	_
27	could	could	MD	_	29	aux	29:AM-MOD
28	be	be	VB	_	29	auxpass	_
29	observed	observe	VBN	pb=observe.01	17	rcmod	_
30	.	.	.	_	6	punct	_

1	Neutron	neutron	NNP	p2=NN	2	nn	_
2	spin-echo	spin-echo	NNP	p2=NN	6	nsubj	6:A0=PAG;10:A0=PAG
3	(	(	-LRB-	_	4	punct	_
4	NSE	nse	NNP	_	2	appos	_
5	)	)	-RRB-	_	4	punct	_
6	measures	measure	VBZ	pb=measure.01	0	root	_
7	cluster	cluster	NN	p2=VBP	8	nn	_
8	dynamics	dynamic	NNS	_	6	dobj	6:A1=PPT
9	by	by	IN	_	6	prep	6:A2=MNR
10	determining	determine	VBG	pb=determine.01	9	pcomp	_
11	their	their	PRP$	_	13	poss	_
12	self	self	NN	_	13	nn	_
13	diffusivity	diffusivity	NN	_	10	dobj	10:A1=PPT
14	(	(	-LRB-	_	16	punct	_
15	as	as	IN	_	16	mark	_
16	opposed	oppose	VBN	pb=oppose.01	10	advcl	_
17	to	to	IN	p2=TO	16	prep	16:A1=PPT
18	collective	collective	JJ	_	19	amod	_
19	diffusivity	diffusivity	NN	_	17	pobj	20:A1=PPT
20	measured	measure	VBN	pb=measure.01	19	partmod	_
21	in	in	IN	_	20	prep	20:A2=MNR
22	dynamic	dynamic	JJ	_	23	amod	_
23	light	light	NN	p2=JJ	24	nn	_
24	scattering	scatter	VBG	p2=NN	21	pobj	_
25	)	)	-RRB-	_	16	punct	_
26	.	.	.	_	6	punct	_

1	Neutrons	neutron	NNS	_	2	nsubj	5:A0=PAG;2:A1=PPT
2	are	be	VBP	pb=be.01	0	root	_
3	able	able	JJ	_	2	acomp	2:A2=PRD
4	to	to	TO	_	5	aux	_
5	probe	probe	VB	pb=probe.01	3	xcomp	_
6	very	very	RB	p2=JJ	7	advmod	_
7	high	high	JJ	_	8	amod	_
8	concentrations	concentration	NNS	_	5	dobj	5:A1=LOC
9	since	since	IN	_	12	mark	_
10	they	they	PRP	_	12	nsubjpass	12:A1=PPT
11	are	be	VBP	_	12	auxpass	_
12	scattered	scatter	VBN	pb=scatter.01	2	advcl	2:AM-CAU
13	only	only	RB	_	14	advmod	_
14	by	by	IN	_	12	agent	12:A0=PAG
15	nuclei	nucleus	NNS	p2=FW	14	pobj	_
16	(	(	-LRB-	_	18	punct	_
17	these	these	DT	_	18	nsubj	18:A0=PAG
18	occupy	occupy	VBP	p2=VB|pb=occupy.01	15	parataxis	_
19	very	very	RB	_	20	advmod	_
20	little	little	JJ	_	21	amod	_
21	space	space	NN	_	18	dobj	18:A1=PPT
22	and	and	CC	_	18	cc	_
23	thus	thus	RB	_	24	advmod	24:AM-DIS
24	appear	appear	VB	p2=VBP|pb=appear.02	18	conj	_
25	dilute	dilute	NN	p2=NNS	24	oprd	24:A1=PPT
26	in	in	IN	_	25	prep	_
27	the	the	DT	_	29	det	_
28	neutron	neutron	NN	_	29	nn	_
29	beam	beam	NN	_	31	poss	_
30	's	's	POS	_	29	possessive	_
31	perspective	perspective	NN	_	26	pobj	_
32	)	)	-RRB-	_	18	punct	_
33	.	.	.	_	2	punct	_

1	Also	also	RB	_	19	advmod	19:AM-DIS
2	the	the	DT	_	5	det	_
3	unrivalled	unrivalled	JJ	_	5	amod	_
4	high	high	JJ	_	5	amod	_
5	resolution	resolution	NN	_	19	nsubj	19:A0=PAG
6	and	and	CC	_	5	cc	_
7	very	very	RB	_	8	advmod	_
8	high	high	JJ	_	10	amod	_
9	neutron	neutron	NN	_	10	nn	_
10	intensity	intensity	NN	_	5	conj	11:A1
11	provided	provided	VBN	pb=provide.01	10	partmod	_
12	by	by	IN	_	11	agent	11:A0
13	the	the	DT	_	17	det	_
14	ILL	ill	NNP	p2=NN	15	nn	_
15	neutron	neutron	NN	_	17	nn	_
16	spin-echo	spin-echo	JJ	p2=HYPH	17	amod	_
17	instrument	instrument	NN	_	12	pobj	_
18	IN15	in15	NNP	p2=NN	17	appos	_
19	allowed	allow	VBD	pb=allow.01	0	root	_
20	a	a	DT	_	22	det	_
21	systematic	systematic	JJ	_	22	amod	_
22	exploration	exploration	NN	_	19	dobj	19:A1=PPT
23	of	of	IN	_	22	prep	_
24	many	many	JJ	_	27	amod	_
25	different	different	JJ	_	27	amod	_
26	mAb	mab	JJ	p2=NN	27	amod	_
27	samples	sample	NNS	_	23	pobj	_
28	.	.	.	_	19	punct	_

1	Using	use	VBG	pb=use.01	12	advcl	12:AM-MNR
2	this	this	DT	_	3	det	_
3	technique	technique	NN	_	1	dobj	1:A1=PPT
4	for	for	IN	_	3	prep	_
5	the	the	DT	_	9	det	_
6	high	high	JJ	_	7	amod	_
7	viscosity	viscosity	NN	_	9	nn	_
8	mAb	mab	NNP	p2=NN	9	nn	_
9	solution	solution	NN	p2=VBD	4	pobj	_
10	the	the	DT	_	11	det	_
11	team	team	NN	_	12	nsubj	1:A0=PAG;12:A0=PAG
12	confirmed	confirm	VBD	pb=confirm.01	0	root	_
13	the	the	DT	_	14	det	_
14	presence	presence	NN	_	12	dobj	12:A1=PPT
15	of	of	IN	_	14	prep	_
16	small	small	JJ	_	18	amod	_
17	extended	extend	VBN	p2=JJ|pb=extend.01	18	amod	_
18	clusters	cluster	NNS	_	15	pobj	17:A1=PPT
19	of	of	IN	_	18	prep	_
20	mAbs	mabs	NNS	p2=NNP	19	pobj	_
21	with	with	IN	_	20	prep	_
22	lifetimes	lifetime	NNS	p2=RB	21	pobj	_
23	sufficiently	sufficiently	RB	_	24	advmod	_
24	long	long	RB	p2=JJ	12	advmod	_
25	to	to	TO	_	26	aux	_
26	have	have	VB	pb=have.03	12	advcl	_
27	an	an	DT	_	28	det	_
28	impact	impact	NN	_	26	dobj	26:AM-PRR
29	on	on	IN	_	28	prep	_
30	bulk	bulk	NN	p2=JJ	31	amod	_
31	solution	solution	NN	_	32	nn	_
32	properties	property	NNS	_	29	pobj	_
33	.	.	.	_	12	punct	_

1	On	on	IN	_	15	prep	15:AM-DIS
2	the	the	DT	_	4	det	_
3	other	other	JJ	_	4	amod	_
4	hand	hand	NN	_	1	pobj	_
5	,	,	,	_	15	punct	_
6	the	the	DT	_	7	det	_
7	diffusivity	diffusivity	NN	_	15	nsubj	15:A0=CAU;8:A1=PPT
8	measured	measure	VBN	p2=VBD|pb=measure.01	7	partmod	_
9	for	for	IN	_	8	prep	8:A2=MNR
10	the	the	DT	_	14	det	_
11	low	low	JJ	_	12	amod	_
12	viscosity	viscosity	NN	_	14	nn	_
13	mAb	mab	NNP	p2=NN	14	nn	_
14	solution	solution	NN	_	9	pobj	_
15	indicated	indicate	VBD	pb=indicate.01	0	root	_
16	no	no	DT	p2=RB	18	det	_
17	such	such	JJ	_	18	amod	_
18	clustering	clustering	NN	p2=VBG	15	dobj	15:A1=PPT
19	at	at	IN	_	15	prep	15:AM-LOC
20	timescales	timescale	NNS	p2=NN	19	pobj	_
21	greater	great	JJR	_	20	amod	_
22	than	than	IN	_	21	prep	_
23	50	0	CD	_	24	num	_
24	nanoseconds	nanosecond	NNS	_	22	pobj	_
25	.	.	.	_	15	punct	_

1	The	the	DT	_	3	det	_
2	two	#crd#	CD	_	3	num	_
3	mAbs	mabs	NNS	p2=NNP	5	nsubj	5:A1=PPT
4	only	only	RB	_	5	advmod	5:AM-ADV
5	differed	differ	VBD	p2=VBN|pb=differ.02	19	ccomp	_
6	in	in	IN	_	5	prep	5:AM-LOC
7	the	the	DT	_	8	det	_
8	sequence	sequence	NN	_	6	pobj	_
9	of	of	IN	_	8	prep	_
10	their	their	PRP$	_	11	poss	_
11	complementarity	complementarity	NN	p2=JJ	12	nsubj	12:A0=PAG
12	determining	determine	VBG	pb=determine.01	9	pcomp	_
13	region	region	NN	_	12	dobj	12:A1=PPT
14	(	(	-LRB-	_	15	punct	_
15	CDR	cdr	NNP	p2=NN	5	npadvmod	_
16	)	)	-RRB-	_	15	punct	_
17	;	;	:	_	19	punct	_
18	this	this	DT	_	19	nsubj	19:A0=CAU
19	shows	show	VBZ	pb=show.01	0	root	_
20	that	that	IN	_	28	complm	_
21	seemingly	seemingly	RB	_	22	advmod	_
22	small	small	JJ	_	23	amod	_
23	changes	change	NNS	_	28	nsubj	28:A0=PAG
24	in	in	IN	_	23	prep	_
25	the	the	DT	_	26	det	_
26	sequence	sequence	NN	_	24	pobj	_
27	can	can	MD	_	28	aux	28:AM-MOD
28	have	have	VB	pb=have.03	19	ccomp	19:A1=PPT
29	profound	profound	JJ	_	30	amod	_
30	consequences	consequence	NNS	_	28	dobj	28:A1=PPT
31	on	on	IN	_	30	prep	_
32	mAb	mab	NNP	p2=VBG	34	nn	_
33	solution	solution	NN	_	34	nn	_
34	behaviour	behaviour	NN	_	31	pobj	_
35	.	.	.	_	19	punct	_

1	Taking	take	VBG	pb=take.01	24	advcl	24:AM-ADV
2	into	into	IN	_	1	prep	1:A2=DIR
3	account	account	NN	_	2	pobj	_
4	these	these	DT	_	5	det	_
5	insights	insight	NNS	_	1	dobj	1:A1=PPT
6	on	on	IN	_	5	prep	_
7	mAb	mab	NNP	_	8	nn	_
8	clustering	clustering	NN	p2=VBG	6	pobj	_
9	,	,	,	_	24	punct	_
10	recent	recent	JJ	_	11	amod	_
11	studies	study	NNS	_	24	dep	_
12	(	(	-LRB-	_	11	punct	_
13	Zarraga	zarraga	NNP	p2=VBN	14	amod	_
14	et	et	NN	p2=VBD	15	nn	_
15	al	al	NNP	p2=IN	24	nsubj	_
16	2013	0	CD	_	15	num	_
17	;	;	:	_	24	punct	_
18	Allmendinger	allmendinger	NNP	p2=JJR	24	nsubj	24:A0=CAU
19	et	et	NN	p2=NNP	20	nn	_
20	al	al	NNP	_	24	nsubj	_
21	2014	0	CD	_	20	num	_
22	)	)	-RRB-	_	18	punct	_
23	have	have	VBP	_	24	aux	_
24	shown	show	VBN	pb=show.01	0	root	_
25	that	that	IN	_	27	complm	_
26	there	there	EX	_	27	expl	_
27	is	be	VBZ	pb=be.02	24	ccomp	24:A1=PPT
28	a	a	DT	_	29	det	_
29	window	window	NN	_	27	attr	27:A1=PPT
30	of	of	IN	_	29	prep	_
31	expulsion	expulsion	NN	_	32	nn	_
32	rates	rate	NNS	_	30	pobj	_
33	through	through	IN	_	29	prep	_
34	a	a	DT	_	36	det	_
35	thin	thin	JJ	_	36	amod	_
36	needle	needle	NN	_	33	pobj	39:A0=PAG
37	that	that	WDT	p2=IN	39	nsubj	39:R-A0
38	reversibly	reversibly	RB	p2=VBZ	39	advmod	39:AM-MNR
39	disrupts	disrupt	VBZ	pb=disrupt.01	36	rcmod	_
40	these	these	DT	_	42	det	_
41	mAb	mab	NNP	p2=JJ	42	nn	_
42	clusters	cluster	NNS	_	39	dobj	39:A1=PPT
43	,	,	,	_	39	punct	_
44	helping	help	VBG	pb=help.01	39	advcl	39:AM-ADV
45	mitigate	mitigate	VB	pb=mitigate.01	44	xcomp	44:A1=PPT
46	the	the	DT	_	48	det	_
47	viscosity	viscosity	NN	p2=JJ	48	nn	_
48	issue	issue	NN	p2=VB	45	dobj	45:A1=PPT
49	without	without	IN	_	44	prep	44:AM-MNR;45:AM-MNR
50	irreversibly	irreversibly	RB	p2=VBG	51	advmod	51:AM-MNR
51	damaging	damage	VBG	pb=damage.01	49	pcomp	_
52	the	the	DT	_	54	det	_
53	individual	individual	JJ	p2=NN	54	amod	_
54	mAbs	mabs	NNS	p2=NNP	51	dobj	51:A1=PPT
55	.	.	.	_	24	punct	_

1	This	this	DT	_	2	nsubj	2:A0=PAG
2	provides	provide	VBZ	pb=provide.01	0	root	_
3	a	a	DT	_	4	det	_
4	basis	basis	NN	_	2	dobj	2:A1=PPT
5	for	for	IN	_	4	prep	_
6	designing	design	VBG	pb=design.01	5	pcomp	_
7	an	an	DT	_	10	det	_
8	optimal	optimal	JJ	p2=NN	9	amod	_
9	device	device	NN	_	10	nn	_
10	system	system	NN	_	6	dobj	6:A1=PRD
11	for	for	IN	_	6	prep	6:A2=GOL
12	delivering	deliver	VBG	pb=deliver.01	11	pcomp	_
13	biopharmaceutical	biopharmaceutical	JJ	_	15	amod	_
14	injectable	injectable	JJ	_	15	amod	_
15	solutions	solution	NNS	_	12	dobj	12:A1=PPT
16	at	at	IN	_	12	prep	12:AM-LOC
17	very	very	RB	_	18	advmod	_
18	high	high	JJ	_	19	amod	_
19	concentrations	concentration	NNS	_	16	pobj	_
20	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	progress	progress	NN	_	7	nsubj	7:A1=PPT;3:AM-PRR
3	made	make	VBN	p2=VBD|pb=make.LV	2	partmod	_
4	in	in	IN	_	3	prep	3:AM-LOC
5	these	these	DT	_	6	det	_
6	studies	study	NNS	_	4	pobj	_
7	is	be	VBZ	pb=be.01	0	root	_
8	due	due	JJ	_	7	acomp	7:A2=PRD
9	in	in	IN	_	8	prep	_
10	part	part	NN	_	9	pobj	_
11	to	to	IN	_	10	prep	_
12	bringing	bring	VBG	pb=bring.01	11	pcomp	_
13	research	research	NN	_	14	nn	_
14	institutions	institution	NNS	_	12	dobj	12:A1=PPT
15	and	and	CC	_	14	cc	_
16	industry	industry	NN	_	14	conj	_
17	together	together	RB	_	12	advmod	12:A3=PRD
18	to	to	TO	_	19	aux	_
19	address	address	VB	pb=address.02	12	advcl	12:AM-PRP
20	practical	practical	JJ	_	21	amod	_
21	problems	problem	NNS	_	19	dobj	19:A1=PPT
22	.	.	.	_	7	punct	_

1	Research	research	NN	p2=VB	2	nn	_
2	institutions	institution	NNS	_	8	nsubj	8:A1=PPT
3	in	in	IN	_	2	prep	_
4	academe	academe	NN	p2=JJ	3	pobj	_
5	and	and	CC	_	4	cc	_
6	national	national	JJ	_	7	amod	_
7	labs	lab	NNS	_	4	conj	_
8	are	be	VBP	pb=be.01	0	root	_
9	often	often	RB	_	8	advmod	8:AM-TMP
10	in	in	IN	_	8	prep	8:A2=PRD
11	search	search	NN	_	10	pobj	_
12	of	of	IN	_	11	prep	_
13	applications	application	NNS	_	12	pobj	_
14	for	for	IN	_	13	prep	_
15	their	their	PRP$	_	17	poss	_
16	technological	technological	JJ	_	17	amod	_
17	solutions	solution	NNS	_	14	pobj	_
18	,	,	,	_	8	punct	_
19	whilst	whilst	IN	_	21	mark	_
20	industry	industry	NN	_	21	nsubj	21:A0=PAG
21	encounters	encounter	VBZ	p2=NNS|pb=encounter.01	8	advcl	_
22	practical	practical	JJ	_	23	amod	_
23	problems	problem	NNS	_	21	dobj	21:A1=PPT
24	when	when	WRB	_	25	advmod	25:R-AM-TMP
25	looking	look	VBG	pb=look.01	21	advcl	21:AM-TMP
26	for	for	IN	_	25	prep	25:A1=GOL
27	solutions	solution	NNS	_	26	pobj	_
28	.	.	.	_	8	punct	_

1	In	in	IN	_	7	prep	7:AM-DIS
2	addition	addition	NN	_	1	pobj	_
3	,	,	,	_	7	punct	_
4	such	such	JJ	_	5	amod	_
5	collaboration	collaboration	NN	_	7	nsubj	7:A0=PAG
6	can	can	MD	_	7	aux	7:AM-MOD
7	spur	spur	VB	pb=spur.01	0	root	_
8	research	research	NN	_	7	dobj	7:A1=PPT
9	in	in	IN	_	8	prep	_
10	adjacent	adjacent	JJ	p2=NN	16	amod	_
11	,	,	,	_	10	punct	_
12	often	often	RB	_	14	advmod	_
13	very	very	RB	_	14	advmod	_
14	important	important	JJ	_	10	conj	_
15	,	,	,	_	16	punct	_
16	fields	field	NNS	p2=VBZ	9	pobj	_
17	.	.	.	_	7	punct	_

1	Dr	dr	NNP	_	3	nn	_
2	Peter	peter	NNP	_	3	nn	_
3	Falus	falus	NNP	_	9	nsubj	9:A0
4	,	,	,	_	3	punct	_
5	instrument	instrument	NN	_	6	nn	_
6	scientist	scientist	NN	_	3	appos	_
7	at	at	IN	_	6	prep	_
8	ILL	ill	NNP	_	7	pobj	_
9	said	say	VBD	pb=say.01	0	root	_
10	:	:	:	_	9	punct	_
11	"	"	``	_	9	punct	_
12	Whilst	whilst	IN	p2=VB	22	mark	_
13	the	the	DT	_	15	det	_
14	potential	potential	JJ	_	15	amod	_
15	impact	impact	NN	_	22	nsubj	22:A1=PPT
16	of	of	IN	_	15	prep	_
17	these	these	DT	_	18	det	_
18	studies	study	NNS	_	16	pobj	_
19	on	on	IN	_	15	prep	_
20	drug	drug	NN	_	21	nn	_
21	design	design	NN	_	19	pobj	_
22	is	be	VBZ	pb=be.01	31	advcl	31:AM-ADV
23	very	very	RB	_	24	advmod	_
24	exciting	exciting	JJ	_	22	acomp	22:A2=PRD
25	,	,	,	_	31	punct	_
26	the	the	DT	_	27	det	_
27	subject	subject	NN	_	31	nsubj	31:A1=PPT
28	of	of	IN	_	27	prep	_
29	protein	protein	NN	_	30	nn	_
30	clustering	clustering	NN	_	28	pobj	_
31	is	be	VBZ	pb=be.01	9	ccomp	9:A1=PPT
32	an	an	DT	_	35	det	_
33	extremely	extremely	RB	_	34	advmod	_
34	interesting	interesting	JJ	_	35	amod	_
35	area	area	NN	_	31	attr	31:A2=PRD
36	in	in	IN	_	35	prep	_
37	its	its	PRP$	_	39	poss	_
38	own	own	JJ	_	39	amod	_
39	right	right	NN	_	36	pobj	_
40	.	.	.	_	9	punct	_

1	A	a	DT	_	2	det	_
2	lot	lot	NN	_	22	nsubj	22:A1=PPT
3	of	of	IN	_	2	prep	_
4	well	well	RB	_	6	hmod	_
5	-	-	HYPH	_	6	hyph	_
6	known	know	VBN	p2=JJ	7	amod	_
7	phenomena	phenomenon	NN	p2=NNS	3	pobj	_
8	,	,	,	_	2	punct	_
9	such	such	JJ	_	10	amod	_
10	as	as	IN	_	2	prep	_
11	the	the	DT	_	12	det	_
12	cataracts	cataract	NNS	_	10	pobj	_
13	in	in	IN	_	12	prep	_
14	our	our	PRP$	_	15	poss	_
15	eyes	eye	NNS	_	13	pobj	_
16	,	,	,	_	2	punct	_
17	or	or	CC	_	2	cc	_
18	Alzheimer	alzheimer	NNP	_	20	poss	_
19	's	's	POS	_	18	possessive	_
20	disease	disease	NN	_	2	conj	_
21	,	,	,	_	22	punct	_
22	are	be	VBP	pb=be.01	0	root	_
23	the	the	DT	_	24	det	_
24	results	result	NNS	_	22	attr	22:A2=PRD
25	of	of	IN	_	24	prep	_
26	proteins	protein	NNS	_	25	pobj	27:A1=PPT
27	clustering	cluster	VBG	p2=VBP|pb=cluster.01	26	partmod	_
28	in	in	IN	_	27	prep	27:AM-LOC
29	our	our	PRP$	_	30	poss	_
30	bodies	body	NNS	_	28	pobj	_
31	.	.	.	_	22	punct	_

1	As	as	IN	_	6	prep	6:AM-ADV
2	a	a	DT	_	3	det	_
3	physicist	physicist	NN	_	1	pobj	_
4	,	,	,	_	6	punct	_
5	I	I	PRP	_	6	nsubj	6:A1=PPT
6	am	be	VBP	pb=be.01	0	root	_
7	interested	interested	JJ	p2=VBN	6	acomp	6:A2=PRD
8	in	in	IN	_	7	prep	_
9	clustering	cluster	VBG	p2=NN|pb=cluster.01	8	pcomp	_
10	in	in	IN	p2=RP	9	prep	9:AM-LOC
11	general	general	JJ	_	10	amod	_
12	,	,	,	_	6	punct	_
13	and	and	CC	_	6	cc	_
14	neutron	neutron	NN	_	15	nn	_
15	techniques	technique	NNS	_	20	nsubj	20:A0=PAG
16	here	here	RB	_	15	advmod	_
17	at	at	IN	_	16	prep	_
18	the	the	DT	_	19	det	_
19	ILL	ill	NNP	p2=NNPS	17	pobj	_
20	provide	provide	VBP	p2=VB|pb=provide.01	6	conj	_
21	a	a	DT	_	27	det	_
22	unique	unique	JJ	_	27	amod	_
23	,	,	,	_	27	punct	_
24	high	high	JJ	_	26	hmod	_
25	-	-	HYPH	_	26	hyph	_
26	resolution	resolution	NN	_	27	nn	_
27	tool	tool	NN	_	20	dobj	20:A1=PPT
28	to	to	TO	_	29	aux	_
29	investigate	investigate	VB	pb=investigate.01	27	infmod	_
30	these	these	DT	_	32	det	_
31	complex	complex	JJ	_	32	amod	_
32	interactions	interaction	NNS	_	29	dobj	29:A1
33	in	in	IN	_	32	prep	_
34	natural	natural	JJ	_	36	amod	_
35	organic	organic	JJ	_	36	amod	_
36	systems	system	NNS	_	33	pobj	_
37	.	.	.	_	20	punct	_
38	"	"	''	_	20	punct	_

